As the U.S. stock market faces turbulence with major indices like the Dow and S&P 500 experiencing significant declines, investors are keenly observing opportunities that might arise from current valuations. In such a volatile environment, identifying stocks that trade below their intrinsic value can present potential investment opportunities, as these may offer room for appreciation when market conditions stabilize.
Name | Current Price | Fair Value (Est) | Discount (Est) |
Flushing Financial (NasdaqGS:FFIC) | $14.27 | $27.60 | 48.3% |
First National (NasdaqCM:FXNC) | $24.06 | $46.63 | 48.4% |
Old National Bancorp (NasdaqGS:ONB) | $21.18 | $40.78 | 48.1% |
Afya (NasdaqGS:AFYA) | $14.58 | $28.59 | 49% |
Western Alliance Bancorporation (NYSE:WAL) | $83.74 | $166.25 | 49.6% |
Symbotic (NasdaqGM:SYM) | $23.97 | $47.09 | 49.1% |
Crown Holdings (NYSE:CCK) | $82.87 | $163.38 | 49.3% |
WEX (NYSE:WEX) | $167.90 | $332.99 | 49.6% |
Progress Software (NasdaqGS:PRGS) | $66.22 | $130.49 | 49.3% |
Paycor HCM (NasdaqGS:PYCR) | $19.58 | $38.44 | 49.1% |
Click here to see the full list of 177 stocks from our Undervalued US Stocks Based On Cash Flows screener.
Let's uncover some gems from our specialized screener.
Overview: Infinera Corporation manufactures semiconductors and provides networking equipment, optical semiconductors, software, and services globally, with a market cap of approximately $1.56 billion.
Operations: The company generates revenue primarily from its optical transport networking equipment, software, and related services segment, amounting to $1.46 billion.
Estimated Discount To Fair Value: 32.1%
Infinera is trading at US$6.58, significantly below its estimated fair value of US$9.69, indicating it may be undervalued based on cash flows. Despite recent financial challenges, including a third-quarter net loss of US$14.31 million and declining revenue, the company is forecasted to achieve profitability over the next three years with high return on equity expectations. Strategic partnerships and technology advancements could support future growth despite current shareholder dilution concerns.
Overview: Zynex, Inc., along with its subsidiaries, designs, manufactures, and markets medical devices for pain treatment and muscle rehabilitation using electrical stimulation; it has a market cap of $267.50 million.
Operations: The company's revenue segment consists of medical devices, generating $193.67 million.
Estimated Discount To Fair Value: 23.9%
Zynex, trading at US$8.17, is significantly below its estimated fair value of US$10.74, suggesting potential undervaluation based on cash flows. Despite a decline in profit margins from 8.6% to 2.5% and high debt levels, earnings are projected to grow at 45.2% annually, outpacing the broader market's growth rate of 15.3%. Recent advancements in pulse oximetry technology could enhance future revenue streams as Zynex targets a multi-billion dollar market opportunity.
Overview: Guild Holdings Company originates, sells, and services residential mortgage loans in the United States and has a market cap of approximately $831.75 million.
Operations: The company's revenue is primarily derived from its origination segment, which accounts for $684.44 million, and its servicing segment, contributing $16.82 million.
Estimated Discount To Fair Value: 32.9%
Guild Holdings, trading at US$13.25, is priced well below its estimated fair value of US$19.74, reflecting potential undervaluation based on cash flows. Despite recent net losses and challenges with debt coverage through operating cash flow, the company is forecasted to achieve profitability within three years and exhibit annual revenue growth of 23.8%, outpacing the broader U.S. market's growth rate. Additionally, Guild Holdings actively seeks acquisitions to bolster its market presence further.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Companies discussed in this article include NasdaqGS:INFN NasdaqGS:ZYXI and NYSE:GHLD.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.